Everest Medicines expects the partnership to complement its renal pipeline and broaden its nephrology product range.
Vietnam Investment Review on MSN

Everest Medicines licenses MT1013 from Micot

SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...